Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Jiangsu Atom Bioscience & Pharmaceutical Co. Ltd. (Atom Bioscience) was founded in 2012. The executive team is primarily from the United States and has extensive experience in the pharmaceutical industry. Atom Bioscience is a research-based pharmaceutical company engaged in new drug discovery and development on treatments for metabolic diseases and cancers. Among the several pipelines that Atom Bioscience develops, ABP-671, a ...
Jiangsu Atom Bioscience & Pharmaceutical Co. Ltd. (Atom Bioscience) was founded in 2012. The executive team is primarily from the United States and has extensive experience in the pharmaceutical industry. Atom Bioscience is a research-based pharmaceutical company engaged in new drug discovery and development on treatments for metabolic diseases and cancers. Among the several pipelines that Atom Bioscience develops, ABP-671, a novel compound for gout treatment has completed Phase I clinical trials in the United States and is undergoing Phase II clinical trials in Australia.

List your booth number for exhibitions, ask us